Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Public ClinicalTrials.gov record NCT01938248. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01938248
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Population Health Research Institute
- Other
- Enrollment
- 4,012 participants
Conditions and interventions
Conditions
Interventions
- Apixaban Drug
- aspirin Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015
- Primary completion
- Oct 26, 2023
- Completion
- Nov 2, 2023
- Last update posted
- Nov 14, 2023
2015 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiovascular Associates of Mesa, PC | Mesa | Arizona | 85206 | — |
| St. Vincent Heart Clinic | Little Rock | Arkansas | 72205 | — |
| Cardiovascular Associates of Marin and San Francisco Medical | Larkspur | California | 94939 | — |
| Aurora Denver Cardiology Associates | Aurora | Colorado | 80012 | — |
| Naples Interventional Cardiac Electrophysiology | Naples | Florida | 34102 | — |
| Langhorne Cardiology Consultants, Inc. | Pensacola | Florida | 32501 | — |
| One Health Cardiology, Owensboro Health, Inc. | Owensboro | Kentucky | 42304 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Sparrow Clinical Research Institute | Lansing | Michigan | 48912 | — |
| Michigan Heart | Ypsilanti | Michigan | 48197 | — |
| University of Missouri Health System | Columbia | Missouri | 65212 | — |
| St. Louis Heart and Vascular | St Louis | Missouri | 63136 | — |
| Glacier View Cardiology | Kalispell | Montana | 59901 | — |
| The Cooper Health System | Camden | New Jersey | 08103 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| The Valley Hospital | Ridgewood | New Jersey | 07450 | — |
| St. Peter's Health Partners Medical Association, PC | Albany | New York | 12205 | — |
| Carolinas Healthcare System | Charlotte | North Carolina | 28203 | — |
| WakeMed | Raleigh | North Carolina | 27610 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Pennsylvania State University | Hershey | Pennsylvania | 17033 | — |
| Research Institute of LG Health / Penn Medicine | Lancaster | Pennsylvania | 17602 | — |
| Virginia Heart | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01938248, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 14, 2023 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01938248 live on ClinicalTrials.gov.